Antibody-mediated gastrointestinal dysmotility in scleroderma☆☆☆
Abstract
Background & Aims: Defects in enteric excitatory neurotransmission have been proposed to underlie the gastrointestinal dysmotility associated with scleroderma (systemic sclerosis). This study investigated whether patients with scleroderma produce antibodies that inhibit M3-muscarinic or neurokinin receptor–mediated intestinal contractions, either directly or via an effect on L-type voltage-gated calcium channels (VGCCs). Methods: Responses of mouse colon longitudinal muscle to stimulation by the muscarinic agonist carbachol (1–300 μmol/L) and neurokinin-1 and -2 receptor agonists were measured in the absence and presence of serum (2%) or immunoglobulin G (IgG) (0.3–1.0 mg/mL) from patients with scleroderma, those with other autoimmune disorders, and healthy controls. The role of L-type VGCCs in carbachol- and tachykinin-evoked contractions was assessed using nicardipine. Results: M3-muscarinic receptor–mediated contractions were inhibited by Ig fractions from 7 of 9 patients with scleroderma (limited and diffuse forms), 4 of 4 patients with primary Sjögren's syndrome, and 3 of 3 patients with secondary Sjögren's syndrome. Ig fractions from healthy controls did not inhibit the M3-muscarinic receptor–mediated contractions. Inhibition by Ig was concentration-dependent; a maximum inhibition of approximately 40% occurred at 0.6 mg/mL IgG. Both M3-muscarinic and neurokinin receptor–mediated contractions were L-type VGCC dependent. Patient sera had no effect on responses to neurokinin receptor stimulation, demonstrating the lack of antibodies inhibiting L-type VGCCs. Conclusions: Functional antibodies specifically inhibiting M3-muscarinic receptor–mediated enteric cholinergic neurotransmission may provide a pathogenic mechanism for the gastrointestinal dysfunction seen in patients with scleroderma.
GASTROENTEROLOGY 2002;123:1144-1150
Abbreviations: NK , neurokinin, RA , rheumatoid arthritis, RF , rheumatoid factor, VGCC , voltage-gated calcium channel
To access this article, please choose from the options below
☆ Address requests for reprints to: Sally Waterman, Ph.D., Department of Immunology, Allergy and Arthritis, Flinders Medical Centre, Bedford Park, South Australia. e-mail: Sally.Waterman@flinders.edu.au; fax: (61) 8-8204 4158.
☆☆ Supported by a National Health and Medical Research Council of Australia (NH&MRC) medical postgraduate scholarship (to F.G.) and a NH&MRC project grant (to T.P.G and S.A.W). S.A.W is a NH&MRC R.D. Wright Fellow.
PII: S0016-5085(02)00220-2
doi:10.1053/gast.2002.36057
© 2002 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Corrections

